JPMorgan analyst Brian Essex lowered the firm’s price target on Rapid7 (RPD) to $23 from $28 and keeps a Neutral rating on the shares as part of an earnings preview. The firm expects another quarter of net net annual recurring revenue deceleration with Rapid7’s execution issues persisting. Sequential ARR weakness will keep the shares pressured, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RPD: